User menu

Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study

Bibliographic reference Zittoun, R ; Suciu, Stefan ; Solbu, G ; Watson, M. ; Muus, P. ; et. al. Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study.In: Blood, Vol. 86, no. 10, p. 1718-1718 (1995)
Permanent URL http://hdl.handle.net/2078.1/62976